EVIDENT

Ebola Virus Disease - correlates of protection, determinants of outcome, and clinical management


Description

In response to the Ebola epidemic in West Africa, a H2020 EU research initiative ‘EVIDENT’ was launched in November 2014. EVIDENT provides a research platform which builds upon the success of the European Mobile Laboratory consortium (EMLab) that is performing Ebola Virus Disease (EVD) diagnostics in affected West African countries since March 2014. EVIDENT’s mandate is to scientifically exploit specimens from EVD patients collected as part of the outbreak response in Guinea, Sierra Leone and Nigeria and to gather critical knowledge on B and T cell immunology, biomarkers, virus evolution, virulence determinants, and transmission of Ebola Virus.

Coordinator
Prof. Stephan Günther
Bernhard-Nocht-Institute for Tropical Medicine
Phone: +49 40 42818-930
Email
Programme
Horizon 2020 & sub-programmes
Duration
24 months (November 2014 - October 2016)
Project funding
€ 1,759,325.25
Project partners
10
About Eurice

Eurice offers knowledge-based consultancy services in project and innovation management.

Eurice Head Office
Heinrich-Hertz-Allee 1
66386 St. Ingbert
Germany
Phone: +49 6894 388130
Email
Eurice Berlin
Alt-Reinickendorf 25
13407 Berlin
Germany
Phone: +49 30 374415840
Email